All our latest news and press releases.
Travers Smith has advised Safestore Holdings plc, a long-standing client and one of Europe's largest owners and operators of self-storage with properties in the UK, France, Netherlands, Spain and Belgium, on its 50/50 joint venture with Nuveen, a leading global asset manager, to acquire Easybox, Italy's second largest self-storage operator by number of stores, for €175m.
Travers Smith is pleased to have advised DBAY Advisors, an international asset management firm which manages a range of funds and investment vehicles for endowments, foundations and other institutional investors, and Aegros Bidco Limited, on the recommended cash offer for Alliance Pharma plc, valued at approximately £350 million.
Travers Smith pensions de-risking team has acted for the Trustee of the C&J Clark Pension Fund (Clarks Scheme) on a £540m buy-in with specialist insurer Pension Insurance Corporation (PIC). This follows an earlier £280m transaction on which the team also advised, meaning that the Clarks Scheme is now fully bought in with PIC. This is a momentous milestone in the journey of the Clarks Scheme and represents a highly valuable outcome for members.
Leading independent law firm Travers Smith LLP is excited to announce it has become a member of Taxand Global in the UK, effective 1st January 2025.
Travers Smith LLP announces the promotion of one lawyer to Director, and three lawyers to Senior Counsel. All promotions are effective from 1 January 2025.
Travers Smith LLP has advised leading investment, asset and development manager Delancey Real Estate ("Delancey") on its partnership with long-income specialists to create Evermill Capital, a new investment manager specialising in asset-backed financing solutions.
Travers Smith has advised Duni AB (Duni Group), Sweden-headquartered market-leading company in providing sustainable and circular solutions for restaurants, catering, and the food industry, on the acquisition of the UK-based tableware company Poppies Europe Ltd (Poppies). The acquisition is subject to regulatory approval in the UK and customary closing conditions, and is expected to be completed in the first half of 2025.
Travers Smith LLP has advised the senior management team of Essential Pharma, a global specialty pharmaceutical business focused on ensuring that patients have access to clinically differentiated, niche, branded pharmaceutical products, on the completion of a €900 million recapitalisation through a Gyrus Capital single-asset Continuation Vehicle led by AlpInvest, and a new strategic financing facility with Sixth Street.